Loading
A phase 3 trial in lung cancer, run by George Washington University, now recruiting.
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery is a phase 3, randomised interventional study registered as NCT06810375 by George Washington University, with a registry enrolment figure of 120 participants, started 2025-03-01 and due to reach its primary completion in 2028-02-28. Interventions recorded: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®); Intercostal nerve block. Conditions listed: Lung Cancers. Primary outcome: Postoperative pain control assessment; Morphine equivalent assessment. Sites: United States. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.